Clinical Neuropsychiatry

SJR Rank #4,295H-index: 42SJR: 1.083Best quartile: Q2Open Access
Journal website: aims, scope and author guidelines
Publisher

Giovanni Fioriti Editore

Country

Italy

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • Psychiatry and Mental HealthQ2

Areas: Medicine

Publication Statistics

2025 Docs3-Year DocsCitable Docs04080120160

Documents per Year

20222025015304560

Detailed Information

ISSN

2385-0787, 1724-4935

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

3.34

References per Document

58.09

Coverage

2006-2026

Scope

The aim of the journal is to critically (without ideological bias) evaluate the current achievements in every field of neuropsychiatry, particularly illness course and treatment effectiveness. It is very important to know how a patient could be defined as improved or recovered, how long a treatment has to last, when therapy works and for whom. These are fundamental issues for Clinical Neuropsychiatry. The main goal of the journal is to collect original papers that directly or indirectly influence the effectiveness of a treatment, particularly focused on Evidence Based Medicine and Clinical Practice. All papers in this journal are peer-reviewed. No person is permitted to take any role in the review of a paper in which they have an interest, e.g., fees or grants from, employment by, consultancy for, shared ownership in, any close relationship with, an organisation whose interests, financial or otherwise, may be affected by the publication of the paper. Giovanni Fioriti Editore’s policy is to publish clinical issue done by experts in their field. All work published is rigorously checked – blind evaluation by at least one reviewer and two editors – whether it is an editorial, review, in-depth article, letter, or a case report.

Metrics from SCImago Journal Rank 2025. View on SCImago